Neuroderm Ltd Ord Sh (NDRM)
38.85 -0.05 (-0.13%) 10/17/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Tue, Oct 17th, 2017
Fiscal Year End Date: 12/31
03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
Cash Flows From Operating Activities | |||||
Net Income | -5,350 | -15,609 | -8,879 | -7,399 | -1,570 |
Depreciation Amortization | 11 | 44 | 32 | 20 | 10 |
Accounts payable and accrued liabilities | 953 | 373 | 12 | 2 | 0 |
Other Working Capital | 473 | -891 | -3,075 | -1,602 | 0 |
Other Operating Activity | -250 | 652 | 1,109 | 2,157 | -1,040 |
Operating Cash Flow | $-4,163 | $-15,431 | $-10,801 | $-6,822 | $-2,600 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -9,000 | -14,965 | -14,965 | -23,510 | 0 |
PPE Investments | -37 | -73 | -55 | -48 | 0 |
Other Investing Activity | 0 | -54 | 0 | 0 | -23,510 |
Investing Cash Flow | $-9,037 | $-15,092 | $-15,020 | $-23,558 | $-23,510 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | N/A | 72,024 | 71,948 | N/A | 0 |
Financing Cash Flow | $N/A | $72,024 | $71,948 | $N/A | $0 |
Exchange Rate Effect | N/A | -2,188 | 2,807 | -144 | -960 |
Beginning Cash Position | 84,735 | 43,238 | 43,238 | 43,238 | 43,230 |
End Cash Position | 71,701 | 84,735 | 89,482 | 13,011 | 15,420 |
Net Cash Flow | $-13,034 | $41,497 | $46,244 | $-30,227 | $-27,810 |
Free Cash Flow | |||||
Operating Cash Flow | -4,163 | -15,431 | -10,801 | -6,822 | -2,600 |
Capital Expenditure | -37 | -73 | -55 | -48 | 0 |
Free Cash Flow | -4,200 | -15,504 | -10,856 | -6,870 | -2,600 |